Axis Wins, Avigilon Tripwire Patent Annulled

Author: John Honovich, Published on Feb 06, 2019

For approaching a decade, the fundamental Object Video tripwire patent has been at the core of an industry debate over patenting and video analytic usage. Now, that patent (acquired by Avigilon a few years ago) has been annulled as Axis / Canon's petition to invalidate the tripwire patent has been granted.

Inside this note, we examine the overall legal battle between Avigilon and Axis, how this was annulled and what impact it has for the industry.

*** *********** * ******, *** *********** ****** ***** ******** ****** has **** ** *** **** ** ** ******** ****** **** patenting *** ***** ******** *****. ***, **** ****** (******** ** Avigilon * *** ***** ***) *** **** ******** ** **** / *****'* ******** ** ********** *** ******** ****** *** **** granted.

****** **** ****, ** ******* *** ******* ***** ****** ******* Avigilon *** ****, *** **** *** ******** *** **** ****** it *** *** *** ********.

[***************]

Annulled ******

************ ****** *** '***** ********'*** **** ******** ** **** *, **** ******** (*** ****** ******), ************ *****:

*** ***** *** ********** ** **** * ******* ***** *********, an ***** ******* ********** ****** **** **** ***** ********* ********* tripwires *** ***********.

Central ******

**** **** ** ****,**** *********** ***** **** *****, *******, *** ****, ******************* *** ** *** **** ** *** **********. *** ****** being ** **** *** ****** ** ** *********** ** ****** any ***** ******** ****** ** ** ******* *********** (**** ********* and ******) ** **** ** ********* ***** *** ********* **** to *********** ******** ********* **** ****** ****** ** ** ****** scene.

Ongoing **** / ******** ******

***** **** ** * *********** ***** ** ******, **** ** part ** * ****** ***** ****** ******* ******** *** **** (and **** ****** *****).** ****, ***** **** ******** *** ****** ************. ***, **** ** *** **** * *****,**** ***** ** ********** * ******** *******, ********* **** *** **** *** ****** ***** **** ********. At *** **** ****, ******** **** **** *** ********* ** NDA.

*** ** **** *** **** * *** *********. *******,******** ******** ****** *****'* ******* ** **** *** $** *******, *********** ********** ***********'* ************* ****** ********* ******** ***** ********'* then *** *** ** * ***** ** ***** *******. ***** the ********* ** *** *******' ******** (** *** ** ******* tend ** ** ******* ******* *** *** ********** ********** ** a ******** ** **** *** **** ****), **** ********** *** often ****** **********.

Impact ** ******** ****** *********

********** **** *** ********** ** (** *****) ******** ****, ********* this ****** ********** * ***** ******* *** ********* ******** **** they *** *** ********* ********'* *******. **** *** **** ********* a ******* *** **** ** **** * *** ****** ****** area ** ******* / ****** ** * ***** **********.

**** **** *** *** ********'* ****** *********, ******, ** *** means. ******** ***** *** **** ************ ** ***** ********* *******, ****** ******** *** ******** *** *** *** **** ********.

****, ** ******* ** *** **** *******. *** ******** ****** was **** *** ***** **, ** **** ***** ** *** next *** *****, *** ****** ***** **** ****** ******* (****** when ** ****** ** ******* ***** ******* ** ****** ***).

Adds ** ******* ************

**** ** *** ****** **** ** * **** **** **** has *** * ****** ****-*** **** * **********. ** ******** 2018,******* ********* ************ ** ***** **** *****-****** ****** ***** *********** * ******* ****** ** ************ **** ******.

Axis / ******** ******** *******

**** **** *** ******** ******** ** ******* ** **** ** the ******.

Comments (15)

Undisclosed #1

02/06/19 04:06pm

....******** ******** ****** *****'* ******* ** **** *** $** *******...******** the ******** *** *** *** **** ********.

*** ******** **** *** ******?

John Honovich

IPVM | In reply to Undisclosed #1 | 02/06/19 04:25pm

***** ********* *** ******** *** ******* ***** ********? * ***'* *** it. ******** ** ** ****** * ******** ****** ******* ** it *** ******** ** ******** ********* ***** ****** ** *** NYSE.

Undisclosed #1

In reply to John Honovich | 02/06/19 04:32pm

***, ****** :(

John Honovich

IPVM | In reply to Undisclosed #1 | 02/07/19 12:57am

*** ******** ********* ** * ***** ****** ******* **** * variety ** ********** **** **** ** *********** **********. *******, *** the ***** ************ ********* ******, ** ** ********.

Avatar

Murat Altuev

AxxonSoft | 02/06/19 04:47pm

***...***** ** *** :)))

Undisclosed Manufacturer #2

02/06/19 05:11pm

******** **** *** ****** *** ****** ** *** *****. ******* stifle **********.

Undisclosed Integrator #3

In reply to Undisclosed Manufacturer #2 | 02/06/19 08:14pm

******* ****** **********.

**** ***** *** ********. * *** *** *** * ************. Does **** **** *** **** **** ******* ** ****? **** certainly ****. **** * **** ******* ********** ** *** ******** patent ****** ** **** ** *** **, *** ******* **** to ***** **, *** *** ***** ****** ** ******* **** some ** ***** ********* *****. *'* *** ****** ******** *** an ****** ** *** - * ****** ***'* ****. *********** was ********** * ****** ***** ** *** ***.

****: * *** *** **** *** ********.

John Honovich

IPVM | In reply to Undisclosed Integrator #3 | 02/06/19 09:08pm

**** **** **** *** **** **** ******* ** ****? **** certainly ****

**** ********* **** ******* *** **** *********** ****** **** ***********. That *** *** ***** **** **, **** ** ****** **** weapon.

*** ** * ***'* ******** ***** **** "******* ****** **********" but * ** ***** **'* **** ** *** **** ****** broad ******* ** ******* **** *** ******* ******* ******* ****** considering ******** ***** *** *** * *******.

Avatar

Jon Dillabaugh

Pro Focus LLC | In reply to John Honovich | 02/07/19 08:33pm

*******! ******* ****** ** * ****** ** ******* **, *** a ******.

Undisclosed Manufacturer #4

In reply to Undisclosed Manufacturer #2 | 02/07/19 11:24pm

******* *** *** ****** **** ********** *** ********* ** ********. Say *** **** ** **** *** **** ***-**** *****. ** there **** ** *******, **** *** ***** **** ******* *********** that **** *** *** **** ***-**** ***** **** **** ****** from ******* *** **** ***** ****** *** **********. ****'* ** oversimplified ****, *** **** ******* ** **** **************.

Undisclosed #1

02/06/19 02:51pm

**

* *** ****, ** * *** *******?

John Honovich

IPVM | In reply to Undisclosed #1 | 02/07/19 12:56am

**'* * ****** ***** ********** **** * ******* ***** ***** patent *********. ** ** *********, *.*.,** **** ******** ********* ******.

* ** ******** ***** ** **** **** ** ***** ****** to ** ** *** **'* ************* * **** ** ********.

Avatar

Skip Cusack

02/07/19 02:03pm

** **** ***, *** ** **** ****? ** *** ******* points ***, *** ****** ** *** ** ****** ****. *** much *** ***** ****** ** ********** **** *** ******, *** much ******* *** **** **** ** **** ** *** ** license ****? ***** **** ****** **** ********** *** ********* ****** again? ** * **** *******, * *** ***** ********* ***** after ****** *** ****** ** ****** ****, "* **** ** could **** **** ******* ** *** **** *****..."

John Honovich

IPVM | In reply to Skip Cusack | 02/07/19 02:15pm

***** **** ****** **** ********** *** ********* ****** *****?

*** ***** ** **** ** **** **** **** * ****** patent. ******** *** *** ** ** ********* ***** **** **** is ******* ** ** ** ********'* ***** *******.

****, **** ** ****, **** **** **** **** * ******* dollars ** ******* ** **** **** *** ***** ***** ** may ** ***** ******** $***,*** ** ********** **** ****** ** save **** ** ****** *********.

Avatar

Jon Dillabaugh

Pro Focus LLC | In reply to John Honovich | 02/07/19 08:36pm

**** **** **** *** **** ***** **** ***** ****** ******* that *** ********* ******* ** ********* ** ********/********? **** ***** have *** ***** *** ***** **** ******** *****'*? ****** ********, because **** *** ****** ***** ************.

Login to read this IPVM report.
Why do I need to log in?
IPVM conducts unique testing and research funded by member's payments enabling us to offer the most independent, accurate and in-depth information.

Most Recent Industry Reports

Verkada Salesman: IPVM "Stuck In A The Stone Age" on Apr 25, 2019
Verkada is 'tackling dinosaurs' and battling those, like IPVM, who are 'stuck in a the stone age'. Verkada's recent sales recruiting promotion...
The HIVIDEO $31 Face Detection DVR Tested on Apr 25, 2019
Face detection in a $31 DVR? That is what "HIVIDEO" (not to be confused with Hikvision, even if the company intends to do that) was promoting at...
Amazon Marketing Pro Installs of Amazon Security Systems on Apr 25, 2019
Is Amazon a threat to conventional providers like ADT, Vivint and Brinks Home Security? Many say no. Now, Amazon is advertising free in-home...
Ex-Integrator Now Growth Strategist Interviewed on Apr 24, 2019
For more than a decade, Scot MacTaggart was a security integrator (at PA-based PSX). In late 2018, he left the industry. He is now a Growth...
19 Facial Recognition Providers Profiled on Apr 23, 2019
IPVM interviewed 19 facial recognition providers at ISC West to understand their claimed accuracy, success and positioning. 9 from China, where...
Locking Down Network Connections Guide on Apr 23, 2019
Accidents and inside attacks are risks when network connections are not locked down. Security and video surveillance systems should be protected...
Hikvision Admits USA Sales Falling on Apr 22, 2019
Hikvision, in a new Chinese financial filing, has admitted that its USA sales are now falling. Less than a year after the US government passed a...
Speco Ultra Intensifier Tested on Apr 22, 2019
While ISC West 2019 named Speco's Ultra Intensifier the best new "Video Surveillance Cameras IP", IPVM testing shows the camera suffers from...
Arecont Favorability Results 2019 on Apr 22, 2019
Arecont's net negativity remained the same in IPVM's 2019 integrator study, though integrator's feeling became relatively more neutral compared to...

The world's leading video surveillance information source, IPVM provides the best reporting, testing and training for 10,000+ members globally. Dedicated to independent and objective information, we uniquely refuse any and all advertisements, sponsorship and consulting from manufacturers.

About | FAQ | Contact